Valuation : Camurus AB

Market Cap 3.49TCr 365.13Cr 314.2Cr 295.61Cr 270.04Cr 505.17Cr 34TCr 506.55Cr 1.36TCr 18TCr 1.37TCr 1.34TCr 57TCr P/E 2026 *
36.5x
P/E 2027 * 23.7x
Enterprise Value 3.04TCr 317.91Cr 273.57Cr 257.39Cr 235.12Cr 439.84Cr 30TCr 441.04Cr 1.18TCr 15TCr 1.19TCr 1.17TCr 50TCr EV / Sales 2026 *
10.6x
EV / Sales 2027 * 7.77x
Free-Float
66.89%
Yield 2026 *
-
Yield 2027 * -
1 day-2.17%
1 week-2.25%
Current month+0.60%
1 month-2.41%
3 months+9.31%
6 months+21.43%
Current year-4.71%
1 week 571.5
Extreme 571.5
608.5
1 month 571.5
Extreme 571.5
644.5
Current year 430.8
Extreme 430.8
710
1 year 430.8
Extreme 430.8
754.5
3 years 282
Extreme 282
754.5
5 years 120
Extreme 120
754.5
10 years 58
Extreme 58
754.5
Manager TitleAgeSince
Chief Executive Officer 63 01/01/2003
Director of Finance/CFO 57 01/07/2025
Chief Tech/Sci/R&D Officer 58 01/01/2025
Director TitleAgeSince
Director/Board Member 63 01/01/2002
Chairman 77 01/01/2015
Director/Board Member 61 07/05/2020
Date Insider Type Main position Quantity % Market Cap. Importance
07/08/26 Sell

Executive/Senior Manager

-5,800 0.0096%
27/02/26 Sell

Chief Executive Officer

55,550 0.0928%
27/02/26 Sell

Chief Executive Officer

1,500 0.0025%
Change 5-day change 1-year change 3-year change Capi.($)
-2.17%-2.25%-18.87%+98.18% 365.13Cr
-0.88%-2.15%+54.71%+106.31% 1,02400Cr
-1.15%+2.68%+53.97%+71.50% 66TCr
-1.44%+0.38%+20.40%+73.05% 45TCr
+0.14%-0.47%+29.49%+38.56% 35TCr
-1.33%+4.72%+24.69%+45.55% 30TCr
-1.15%+0.30%-1.49%+12.31% 25TCr
-1.55%+1.11%+56.10%+70.32% 24TCr
-0.88%+1.15%-17.09%-54.39% 21TCr
-0.15%+3.65%+33.90%+96.99% 19TCr
Average -1.11%+0.76%+23.58%+55.84% 36.82TCr
Weighted average by Cap. -1.10%+0.54%+36.57%+66.25%

Financials

2026 *2027 *
Net sales 285.66Cr 30Cr 26Cr 24Cr 22Cr 41Cr 2.82TCr 41Cr 110.85Cr 1.45TCr 112.12Cr 109.68Cr 4.66TCr 374.78Cr 39Cr 34Cr 32Cr 29Cr 54Cr 3.7TCr 54Cr 145.43Cr 1.9TCr 147.11Cr 143.9Cr 6.11TCr
Net income 95Cr 9.92Cr 8.54Cr 8.03Cr 7.34Cr 14Cr 936.63Cr 14Cr 37Cr 480.55Cr 37Cr 36Cr 1.55TCr 145.22Cr 15Cr 13Cr 12Cr 11Cr 21Cr 1.43TCr 21Cr 56Cr 735.33Cr 57Cr 56Cr 2.37TCr
Net Debt -451.72Cr -47Cr -41Cr -38Cr -35Cr -65Cr -4.46TCr -66Cr -175.29Cr -2.29TCr -177.3Cr -173.43Cr -7.37TCr -580.71Cr -61Cr -52Cr -49Cr -45Cr -84Cr -5.73TCr -84Cr -225.34Cr -2.94TCr -227.93Cr -222.96Cr -9.47TCr
Logo Camurus AB
Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.
Employees
316
Date Price Change Volume
04/26/04 SEK 587.00 -2.17% 40,835
03/26/03 SEK 600.00 +1.01% 51,590
02/26/02 SEK 594.00 +0.59% 66,895
01/26/01 SEK 590.50 +1.20% 71,430
31/26/31 SEK 583.50 -2.83% 1,84,554
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
587.00SEK
Average target price
793.00SEK
Spread / Average Target
+35.09%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CAMX Stock